4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-062079
Chief Medical Officer sold 2,381 shares at an average $28.27 ($67,310)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farwell Wildon Chief Medical Officer | 2024-05-16 | Sale 10b5-1 | −1,956 | $28.20 | $55,159 | 148,604 | D |
| Farwell Wildon Chief Medical Officer | 2024-05-16 | Sale 10b5-1 | −425 | $28.59 | $12,151 | 148,179 | D |
| Open-market sales · 2,381 sh · avg $28.27 · $67,310 | |||||||
Loading xslF345X05/ownership.xml…